TOTUS MEDICINES
Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome.
TOTUS MEDICINES
Industry:
Biopharma Biotechnology Medical
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.totusmedicines.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
NeoScientific
NeoScientific is a dynamic and growing provider of high-quality biology research reagents, tools, and custom services.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northpond Ventures
Northpond Ventures investment in Series A - Totus Medicines
Camford Capital
Camford Capital investment in Series A - Totus Medicines
DCVC Bio
DCVC Bio investment in Series A - Totus Medicines
Social Impact Capital
Social Impact Capital investment in Seed Round - Totus Medicines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-23 | Totus Medicines Hires Corporate Strategy Leader Laura Miller |
Official Site Inspections
http://www.totusmedicines.com Semrush global rank: 4.22 M Semrush visits lastest month: 2.79 K
- Host name: 434307.cloudwaysapps.com
- IP address: 157.245.82.48
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Totus Medicines"
Totus | Totus Medicines
Researchers have discovered hundreds of drug targets to treat diseaseโand find more every day. But until recently, 90 % of these targets have been considered โ undruggable,โ and therefore untreatable. Using our revolutionary high โฆSee details»
Totus Medicines - Crunchbase Company Profile
Totus Medicines may be growing as evidenced by the closing of a significant Series B funding round, which amounted to $66 million. This substantial influx of capital typically indicates investor confidence and provides the financial โฆSee details»
Platform - Totus
Exponentially evolving covalent library We have the worldโs most comprehensive library of covalent chemistries, and as The Totus Platform learns, that library grows.See details»
Totus Medicines - LinkedIn
Totus Medicines | 2,882 followers on LinkedIn. Making every disease treatable by making the total human genome druggable. | Totus Medicines is applying revolutionary chemical biology technologies ...See details»
Totus Medicines - PitchBook
Totus Medicines General Information Description. Developer of chemical biology technologies designed to create therapeutics for untreatable diseases. The company's technology uses the power of covalent bonding and a proprietary โฆSee details»
Totus Medicines - Overview, News & Similar companies - ZoomInfo
Jan 1, 2024 Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors TOS-358 is the first highly specific, potent inhibitor of PI3Kฮฑ โฆSee details»
This Biotech Company Raised $40 Million To Develop โฆ
Dec 9, 2021 It was this experience that led Dhawan, 33, to cofound Totus Medicines in 2019. On Thursday, the Cambridge-based company announced it raised a $40 million series A round, bringing its total ...See details»
Totus Medicines Announces Appointment of Nassim Usman, โฆ
Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent libraries and AI tools, announced today that Nassim Usman, Ph.D., has been โฆSee details»
Totus Medicines Partners with Mila to Advance Drug Discovery ...
Mar 24, 2022 Mila is a nonprofit organization recognized worldwide for its significant contributions to the field of deep learning, particularly in language modeling, machine โฆSee details»
Totus | Article - totusmedicines.com
May 16, 2024 For more information, please visit totusmedicines.com and follow Totus on LinkedIn and Twitter/X. Contact: [email protected]. External Contact: Brian Mullen. โฆSee details»
Totus Medicines Announces Strategic Multi-Target Research โฆ
May 16, 2024 For more information, please visit totusmedicines.com and follow Totus on LinkedIn and Twitter/X. Contact: [email protected]. External Contact: Brian Mullen โฆSee details»
Totus Medicines Emerges from Stealth with ... - Markets Insider
Dec 9, 2021 For more information, please visit totusmedicines.com and follow Totus on LinkedIn and Twitter. Media Contact: Megan O'Leary [email protected] (202) 331-1002See details»
Totus Medicines Announces First Patient Dosed in Phase
TOS-358 is the first highly specific, potent inhibitor of PI 3 KฮฑEMERYVILLE, Calif. , April 13, 2023 โ Totus Medicines, the drug discovery and development company committed to ending the โฆSee details»
Totus Medicines Emerges from Stealth with Revolutionary Drug โฆ
Dec 9, 2021 For more information, please visit totusmedicines.com and follow Totus on LinkedIn and Twitter. Media Contact: Megan O'Leary [email protected] (202) 331-1002. SOURCE Totus โฆSee details»
Totus tots up $40M in series A funding to go after competitive โฆ
Dec 9, 2021 Totus Medicines is making a play for the PI3Kฮฑ inhibitor market. Exiting stealth with a $40 million series A round, the Massachusetts-based biotech plans to advance a molecule โฆSee details»
Totus | Clinical Trials - totusmedicines.com
For more information and a list of participating clinical trial sites, clinicaltrials.gov Study NCT05683418 or email [email protected] Totus Medicines. Our lifeโs work is โฆSee details»
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of โฆ
Apr 13, 2023 TOS-358 is the first highly specific, potent inhibitor of PI3Kฮฑ. EMERYVILLE, Calif. , April 13, 2023 /PRNewswire/ -- Totus Medicines, the drug discovery and development โฆSee details»
Pipeline - Totus
Our aim is to develop medicines that will have the greatest impact on as many patients as possible. To assess and prioritize targets for our pipeline, our internally developed Target โฆSee details»
News - Totus
Oct 19, 2023 Applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.See details»